Patient Engagement Solutions Market Size & Share Analysis - Emerging Trends, Growth Opportunities, Competitive Landscape, and Forecasts (2025 - 2032)
This Report Provides In-Depth Analysis of the Patient Engagement Solutions Market Report Prepared by P&S Intelligence, Segmented by Education (Software, Hardware, Services), Delivery Mode (Web-Based, On-Premises, Cloud-Based), Application (Health Management, Home Health Management, Social and Behavioral Health Management, Financial Health Management), Therapeutic Area (Chronic Diseases, Women's Health, Fitness, Mental Health), End User (Providers, Payers, Patients), and Geographical Outlook for the Period of 2019 to 2032
- Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Component
- 1.4.2. Market Size Breakdown, by Delivery Mode
- 1.4.3. Market Size Breakdown, by Application
- 1.4.4. Market Size Breakdown, by Therapeutic Area
- 1.4.5. Market Size Breakdown, by End User
- 1.4.6. Market Size Breakdown, by Region
- 1.5. Market Data Reporting Unit
- 1.5.1. Revenue
- 1.6. Key Stakeholders
- Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
- 2.1. Secondary Research
- Chapter 3. Executive Summary
- Chapter 4. Market Indicators
- Chapter 5. Industry Outlook
- 5.1. Industry Background
- 5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
- 5.3. Impact of COVID-19
- 5.4. Sociopolitical Impact
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Bargaining Power of Buyers
- 5.5.2. Bargaining Power of Suppliers
- 5.5.3. Threat of New Entrants
- 5.5.4. Intensity of Rivalry
- 5.5.5. Threat of Substitutes
- 5.6. Innovation and Technology Trends
- 5.7. Economic and Regulatory Impact
- 5.8. Market Entry Strategies
- Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Market Share of Key Players (2024)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East & Africa
- 6.3. Competitive Benchmarking of Key Players
- 6.4. Recent Strategic Developments by Key Players
- 6.5. Company Leadership Matrix
- Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Component (2019-2032)
- 7.3. Market Revenue, by Delivery Mode (2019-2032)
- 7.4. Market Revenue, by Application (2019-2032)
- 7.5. Market Revenue, by Therapeutic Area (2019-2032)
- 7.6. Market Revenue, by End User (2019-2032)
- 7.7. Market Revenue, by Region (2019-2032)
- Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Component (2019-2032)
- 8.3. Market Revenue, by Delivery Mode (2019-2032)
- 8.4. Market Revenue, by Application (2019-2032)
- 8.5. Market Revenue, by Therapeutic Area (2019-2032)
- 8.6. Market Revenue, by End User (2019-2032)
- 8.7. Market Revenue, by Country (2019-2032)
- Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Component (2019-2032)
- 9.3. Market Revenue, by Delivery Mode (2019-2032)
- 9.4. Market Revenue, by Application (2019-2032)
- 9.5. Market Revenue, by Therapeutic Area (2019-2032)
- 9.6. Market Revenue, by End User (2019-2032)
- 9.7. Market Revenue, by Country (2019-2032)
- Chapter 10. Asia-Pacific Market
- 10.1. Overview
- 10.2. Market Revenue, by Component (2019-2032)
- 10.3. Market Revenue, by Delivery Mode (2019-2032)
- 10.4. Market Revenue, by Application (2019-2032)
- 10.5. Market Revenue, by Therapeutic Area (2019-2032)
- 10.6. Market Revenue, by End User (2019-2032)
- 10.7. Market Revenue, by Country (2019-2032)
- Chapter 11. Latin America Market
- 11.1. Overview
- 11.2. Market Revenue, by Component (2019-2032)
- 11.3. Market Revenue, by Delivery Mode (2019-2032)
- 11.4. Market Revenue, by Application (2019-2032)
- 11.5. Market Revenue, by Therapeutic Area (2019-2032)
- 11.6. Market Revenue, by End User (2019-2032)
- 11.7. Market Revenue, by Country (2019-2032)
- Chapter 12. Middle East & Africa Market
- 12.1. Overview
- 12.2. Market Revenue, by Component (2019-2032)
- 12.3. Market Revenue, by Delivery Mode (2019-2032)
- 12.4. Market Revenue, by Application (2019-2032)
- 12.5. Market Revenue, by Therapeutic Area (2019-2032)
- 12.6. Market Revenue, by End User (2019-2032)
- 12.7. Market Revenue, by Country (2019-2032)
- Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Economic Indicators
- 13.3. Demographics and Population Insights
- 13.4. Regional Hotspots
- 13.5. Growth Drivers
- 13.6. Challenges and Barriers
- 13.7. Competitive Strategies
- 13.8. Emerging Players
- 13.9. Compliance Requirements
- 13.10. Emerging Investment Areas
- 13.11. Major Ongoing Projects
- 13.12. Market Size and Forecast
- 13.12.1. Market Revenue, by Component (2019-2032)
- 13.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 13.12.3. Market Revenue, by Application (2019-2032)
- 13.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 13.12.5. Market Revenue, by End User (2019-2032)
- Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Economic Indicators
- 14.3. Demographics and Population Insights
- 14.4. Regional Hotspots
- 14.5. Growth Drivers
- 14.6. Challenges and Barriers
- 14.7. Competitive Strategies
- 14.8. Emerging Players
- 14.9. Compliance Requirements
- 14.10. Emerging Investment Areas
- 14.11. Major Ongoing Projects
- 14.12. Market Size and Forecast
- 14.12.1. Market Revenue, by Component (2019-2032)
- 14.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 14.12.3. Market Revenue, by Application (2019-2032)
- 14.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 14.12.5. Market Revenue, by End User (2019-2032)
- Chapter 15. U.K. Market
- 15.1. Overview
- 15.2. Economic Indicators
- 15.3. Demographics and Population Insights
- 15.4. Regional Hotspots
- 15.5. Growth Drivers
- 15.6. Challenges and Barriers
- 15.7. Competitive Strategies
- 15.8. Emerging Players
- 15.9. Compliance Requirements
- 15.10. Emerging Investment Areas
- 15.11. Major Ongoing Projects
- 15.12. Market Size and Forecast
- 15.12.1. Market Revenue, by Component (2019-2032)
- 15.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 15.12.3. Market Revenue, by Application (2019-2032)
- 15.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 15.12.5. Market Revenue, by End User (2019-2032)
- Chapter 16. Germany Market
- 16.1. Overview
- 16.2. Economic Indicators
- 16.3. Demographics and Population Insights
- 16.4. Regional Hotspots
- 16.5. Growth Drivers
- 16.6. Challenges and Barriers
- 16.7. Competitive Strategies
- 16.8. Emerging Players
- 16.9. Compliance Requirements
- 16.10. Emerging Investment Areas
- 16.11. Major Ongoing Projects
- 16.12. Market Size and Forecast
- 16.12.1. Market Revenue, by Component (2019-2032)
- 16.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 16.12.3. Market Revenue, by Application (2019-2032)
- 16.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 16.12.5. Market Revenue, by End User (2019-2032)
- Chapter 17. France Market
- 17.1. Overview
- 17.2. Economic Indicators
- 17.3. Demographics and Population Insights
- 17.4. Regional Hotspots
- 17.5. Growth Drivers
- 17.6. Challenges and Barriers
- 17.7. Competitive Strategies
- 17.8. Emerging Players
- 17.9. Compliance Requirements
- 17.10. Emerging Investment Areas
- 17.11. Major Ongoing Projects
- 17.12. Market Size and Forecast
- 17.12.1. Market Revenue, by Component (2019-2032)
- 17.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 17.12.3. Market Revenue, by Application (2019-2032)
- 17.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 17.12.5. Market Revenue, by End User (2019-2032)
- Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Economic Indicators
- 18.3. Demographics and Population Insights
- 18.4. Regional Hotspots
- 18.5. Growth Drivers
- 18.6. Challenges and Barriers
- 18.7. Competitive Strategies
- 18.8. Emerging Players
- 18.9. Compliance Requirements
- 18.10. Emerging Investment Areas
- 18.11. Major Ongoing Projects
- 18.12. Market Size and Forecast
- 18.12.1. Market Revenue, by Component (2019-2032)
- 18.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 18.12.3. Market Revenue, by Application (2019-2032)
- 18.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 18.12.5. Market Revenue, by End User (2019-2032)
- Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Economic Indicators
- 19.3. Demographics and Population Insights
- 19.4. Regional Hotspots
- 19.5. Growth Drivers
- 19.6. Challenges and Barriers
- 19.7. Competitive Strategies
- 19.8. Emerging Players
- 19.9. Compliance Requirements
- 19.10. Emerging Investment Areas
- 19.11. Major Ongoing Projects
- 19.12. Market Size and Forecast
- 19.12.1. Market Revenue, by Component (2019-2032)
- 19.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 19.12.3. Market Revenue, by Application (2019-2032)
- 19.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 19.12.5. Market Revenue, by End User (2019-2032)
- Chapter 20. China Market
- 20.1. Overview
- 20.2. Economic Indicators
- 20.3. Demographics and Population Insights
- 20.4. Regional Hotspots
- 20.5. Growth Drivers
- 20.6. Challenges and Barriers
- 20.7. Competitive Strategies
- 20.8. Emerging Players
- 20.9. Compliance Requirements
- 20.10. Emerging Investment Areas
- 20.11. Major Ongoing Projects
- 20.12. Market Size and Forecast
- 20.12.1. Market Revenue, by Component (2019-2032)
- 20.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 20.12.3. Market Revenue, by Application (2019-2032)
- 20.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 20.12.5. Market Revenue, by End User (2019-2032)
- Chapter 21. Japan Market
- 21.1. Overview
- 21.2. Economic Indicators
- 21.3. Demographics and Population Insights
- 21.4. Regional Hotspots
- 21.5. Growth Drivers
- 21.6. Challenges and Barriers
- 21.7. Competitive Strategies
- 21.8. Emerging Players
- 21.9. Compliance Requirements
- 21.10. Emerging Investment Areas
- 21.11. Major Ongoing Projects
- 21.12. Market Size and Forecast
- 21.12.1. Market Revenue, by Component (2019-2032)
- 21.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 21.12.3. Market Revenue, by Application (2019-2032)
- 21.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 21.12.5. Market Revenue, by End User (2019-2032)
- Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Economic Indicators
- 22.3. Demographics and Population Insights
- 22.4. Regional Hotspots
- 22.5. Growth Drivers
- 22.6. Challenges and Barriers
- 22.7. Competitive Strategies
- 22.8. Emerging Players
- 22.9. Compliance Requirements
- 22.10. Emerging Investment Areas
- 22.11. Major Ongoing Projects
- 22.12. Market Size and Forecast
- 22.12.1. Market Revenue, by Component (2019-2032)
- 22.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 22.12.3. Market Revenue, by Application (2019-2032)
- 22.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 22.12.5. Market Revenue, by End User (2019-2032)
- Chapter 23. India Market
- 23.1. Overview
- 23.2. Economic Indicators
- 23.3. Demographics and Population Insights
- 23.4. Regional Hotspots
- 23.5. Growth Drivers
- 23.6. Challenges and Barriers
- 23.7. Competitive Strategies
- 23.8. Emerging Players
- 23.9. Compliance Requirements
- 23.10. Emerging Investment Areas
- 23.11. Major Ongoing Projects
- 23.12. Market Size and Forecast
- 23.12.1. Market Revenue, by Component (2019-2032)
- 23.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 23.12.3. Market Revenue, by Application (2019-2032)
- 23.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 23.12.5. Market Revenue, by End User (2019-2032)
- Chapter 24. South Korea Market
- 24.1. Overview
- 24.2. Economic Indicators
- 24.3. Demographics and Population Insights
- 24.4. Regional Hotspots
- 24.5. Growth Drivers
- 24.6. Challenges and Barriers
- 24.7. Competitive Strategies
- 24.8. Emerging Players
- 24.9. Compliance Requirements
- 24.10. Emerging Investment Areas
- 24.11. Major Ongoing Projects
- 24.12. Market Size and Forecast
- 24.12.1. Market Revenue, by Component (2019-2032)
- 24.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 24.12.3. Market Revenue, by Application (2019-2032)
- 24.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 24.12.5. Market Revenue, by End User (2019-2032)
- Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Economic Indicators
- 25.3. Demographics and Population Insights
- 25.4. Regional Hotspots
- 25.5. Growth Drivers
- 25.6. Challenges and Barriers
- 25.7. Competitive Strategies
- 25.8. Emerging Players
- 25.9. Compliance Requirements
- 25.10. Emerging Investment Areas
- 25.11. Major Ongoing Projects
- 25.12. Market Size and Forecast
- 25.12.1. Market Revenue, by Component (2019-2032)
- 25.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 25.12.3. Market Revenue, by Application (2019-2032)
- 25.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 25.12.5. Market Revenue, by End User (2019-2032)
- Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Economic Indicators
- 26.3. Demographics and Population Insights
- 26.4. Regional Hotspots
- 26.5. Growth Drivers
- 26.6. Challenges and Barriers
- 26.7. Competitive Strategies
- 26.8. Emerging Players
- 26.9. Compliance Requirements
- 26.10. Emerging Investment Areas
- 26.11. Major Ongoing Projects
- 26.12. Market Size and Forecast
- 26.12.1. Market Revenue, by Component (2019-2032)
- 26.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 26.12.3. Market Revenue, by Application (2019-2032)
- 26.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 26.12.5. Market Revenue, by End User (2019-2032)
- Chapter 27. U.A.E. Market
- 27.1. Overview
- 27.2. Economic Indicators
- 27.3. Demographics and Population Insights
- 27.4. Regional Hotspots
- 27.5. Growth Drivers
- 27.6. Challenges and Barriers
- 27.7. Competitive Strategies
- 27.8. Emerging Players
- 27.9. Compliance Requirements
- 27.10. Emerging Investment Areas
- 27.11. Major Ongoing Projects
- 27.12. Market Size and Forecast
- 27.12.1. Market Revenue, by Component (2019-2032)
- 27.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 27.12.3. Market Revenue, by Application (2019-2032)
- 27.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 27.12.5. Market Revenue, by End User (2019-2032)
- Chapter 28. Saudi Arabia Market
- 28.1. Overview
- 28.2. Economic Indicators
- 28.3. Demographics and Population Insights
- 28.4. Regional Hotspots
- 28.5. Growth Drivers
- 28.6. Challenges and Barriers
- 28.7. Competitive Strategies
- 28.8. Emerging Players
- 28.9. Compliance Requirements
- 28.10. Emerging Investment Areas
- 28.11. Major Ongoing Projects
- 28.12. Market Size and Forecast
- 28.12.1. Market Revenue, by Component (2019-2032)
- 28.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 28.12.3. Market Revenue, by Application (2019-2032)
- 28.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 28.12.5. Market Revenue, by End User (2019-2032)
- Chapter 29. South Africa Market
- 29.1. Overview
- 29.2. Economic Indicators
- 29.3. Demographics and Population Insights
- 29.4. Regional Hotspots
- 29.5. Growth Drivers
- 29.6. Challenges and Barriers
- 29.7. Competitive Strategies
- 29.8. Emerging Players
- 29.9. Compliance Requirements
- 29.10. Emerging Investment Areas
- 29.11. Major Ongoing Projects
- 29.12. Market Size and Forecast
- 29.12.1. Market Revenue, by Component (2019-2032)
- 29.12.2. Market Revenue, by Delivery Mode (2019-2032)
- 29.12.3. Market Revenue, by Application (2019-2032)
- 29.12.4. Market Revenue, by Therapeutic Area (2019-2032)
- 29.12.5. Market Revenue, by End User (2019-2032)
- Chapter 30. Company Profiles
- Chapter 31. Appendix
- 31.1. Sources and References
- 31.2. Related Reports
